Blueberries, due to their phenolic compounds, show potential as both dietary and supplemental anti-cancer agents by inhibiting cancer cell growth and promoting apoptosis.
The researchers synthesized evidence from previous in vitro, in vivo, and a limited number of clinical studies to evaluate the anti-cancer efficacy of blueberries. These studies primarily focused on the fruit's phenolic compounds, which are known for their high antioxidant capacity. The mechanisms underlying the anti-cancer effects of blueberries were analyzed, such as their capacity to inhibit the production of pro-inflammatory molecules, oxidative stress, and products of oxidative stress like DNA damage.
In the discussion of the results, it was found that blueberries manifest their anti-cancer properties through the inhibition of cancer cell proliferation and induction of apoptosis. This makes them promising functional foods and nutritional supplements. The evidence strongly indicates the high potential of blueberries as a preventive measure against carcinogenesis, solidifying their position as an anti-cancer fruit. The potential of blueberries in this field certainly demands further exploration.
